Anthracosis: Clinical Trials

4 trials for Anthracosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown, 1 completed, 1 not yet recruiting. 2 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable2Not yet recruiting 1, Unknown 1
Phase 22Completed 1, Unknown 1

Follow Anthracosis: new trials by email Literature Review of Anthracosis trials Research Report on Anthracosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
QuitAid (pharmacist-delivered MTM), Nicotine Replacement Therapy (NRT) - Tobacco Use Cessation, Tobacco Use Disorder
Not applicableNot yet recruitingUniversity of Virginia1202026-09-012026-07-10
TCM for Coal Worker's Pneumoconiosis
Chinese medicine compound combined with symptomatic treatments, Chinese medicine compound placebo combined with symptomatic treatments - Coal Worker's Pneumoconiosis
Not applicableUnknownHenan University of Traditional Chinese Medicine2222021-04-152021-04-12
The Nintedanib in Progressive Pneumoconiosis Study (NiPPS): a Collaborative NSW Treatment Trial
Nintedanib 150 MG [Ofev] - Pneumoconiosis Coal, Asbestosis
Phase 2UnknownHoldsworth House Medical Practice1002020-10-092021-02-10
Examination of Pirfenidone (EsbrietĀ®) Therapy in Coal Workers' Pneumoconiosis With Pulmonary Fibrosis
Pirfenidone - Coal Workers' Pneumoconiosis (Complicated)
Phase 2CompletedPulmonary Research of Abingdon, LLC502020-08-312024-07-16

Narrower conditions

Asbestosis (1)  ·  Silicosis (1)  ·  Smoking Cessation (1)  ·  Tobacco Use Cessation (1)  ·  Tobacco Use Disorder (1)

Broader conditions

Lung Diseases (4)  ·  Lung Diseases, Interstitial (4)  ·  Lung Injury (4)  ·  Pneumoconiosis (4)  ·  Respiratory Tract Diseases (4)  ·  Behavior (1)  ·  Chemically-Induced Disorders (1)  ·  Health Behavior (1)  ·  Mental Disorders (1)  ·  Occupational Diseases (1)  ·  Substance-Related Disorders (1)

Interventions

Medication Therapy Management (1)  ·  Nicotine Replacement Therapy (1)  ·  nintedanib (1)  ·  pirfenidone (1)

Sponsors

Henan University of Traditional Chinese Medicine (1)  ·  Holdsworth House Medical Practice (1)  ·  Pulmonary Research of Abingdon, LLC (1)  ·  University of Virginia (1)

Countries

United States (2)  ·  Australia (1)  ·  China (1)

Top investigators

Deborah Yates, A/Prof (1)  ·  Drew Harris, MD (1)  ·  Emory Robinette, MD (1)  ·  Jian-sheng Li, Professor (1)  ·  Melissa A Little, PhD, MPH (1)

NIH funding

P30CA044579 (1)